BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 38926862)

  • 1. Hypertension and cardiac damage in pheochromocytoma and paraganglioma patients: a large-scale single-center cohort study.
    Yu Y; Chen C; Meng L; Han W; Zhang Y; Zhang Z; Yang Y
    BMC Cardiovasc Disord; 2024 Jun; 24(1):325. PubMed ID: 38926862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk Factors for Cardiac Complications in Patients With Pheochromocytoma and Paraganglioma: A Retrospective Single-Center Study.
    Zhao L; Meng X; Mei Q; Fan H; Liu Y; Zhou X; Zhu H; Zhang S
    Front Endocrinol (Lausanne); 2022; 13():877341. PubMed ID: 35721724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac Changes and Their Reversal Following Curative Surgery in Pheochromocytoma: PheoCard Prospective Cohort Study.
    Vishvak Chanthar KMM; Khanna R; Agarwal G; Rout SR; Kapoor A; Sabaretnam M; Chand G; Mishra A; Agarwal A; Mishra SK
    World J Surg; 2023 Feb; 47(2):304-311. PubMed ID: 36210362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rates of Pheochromocytoma/Paraganglioma Screening in At-Risk Populations.
    Grigoryan S; Nhan W; Zhang L; Urban C; Zhao L; Turcu AF
    J Clin Endocrinol Metab; 2023 May; 108(6):e343-e349. PubMed ID: 36469797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Left Ventricular Structural and Functional Alterations in Patients With Pheochromocytoma/Paraganglioma Before and After Surgery.
    Dobrowolski P; Januszewicz A; Klisiewicz A; Gosk-Przybyłek M; Pęczkowska M; Kabat M; Kwapiszewska A; Warchoł-Celińska E; Ambroziak U; Doroszko A; Toutounchi S; Gałązka Z; Bednarczuk T; Górnicka B; Januszewicz M; Hoffman P; Lenders JWM; Eisenhofer G; Prejbisz A
    JACC Cardiovasc Imaging; 2020 Dec; 13(12):2498-2509. PubMed ID: 32950457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Presentation and Treatment Outcomes of Children and Adolescents With Pheochromocytoma and Paraganglioma in a Single Center in Korea.
    Park H; Kim MS; Lee J; Kim JH; Jeong BC; Lee S; Lee SK; Cho SY; Jin DK
    Front Endocrinol (Lausanne); 2020; 11():610746. PubMed ID: 33584544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TAKOTSUBO-LIKE CARDIOMYOPATHY IN A LARGE COHORT OF PATIENTS WITH PHEOCHROMOCYTOMA AND PARAGANGLIOMA.
    Gagnon N; Mansour S; Bitton Y; Bourdeau I
    Endocr Pract; 2017 Oct; 23(10):1178-1192. PubMed ID: 28704094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intrarenal hemodynamics and kidney function in pheochromocytoma and paraganglioma before and after surgical treatment.
    Januszewicz M; Dobrowolski P; Januszewicz A; Warchoł-Celińska E; Jóźwik-Plebanek K; Motyl D; Kabat M; Pęczkowska M; Michałowska I; Ambroziak U; Toutounchi S; Gałązka Z; Courcelles L; Pappaccogli M; Eisenhofer G; Persu A; Lenders JWM; Kądziela J; Prejbisz A
    Blood Press; 2021 Jun; 30(3):172-179. PubMed ID: 33586556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting Left Ventricular Mechanics In Patients With Pheochromocytoma/Paraganglioma: An Updated Meta-analysis.
    Cuspidi C; Gherbesi E; Faggiano A; Sala C; Carugo S; Grassi G; Tadic M
    Am J Hypertens; 2023 May; 36(6):333-340. PubMed ID: 36617865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute catecholamine cardiomyopathy in patients with phaeochromocytoma or functional paraganglioma.
    Giavarini A; Chedid A; Bobrie G; Plouin PF; Hagège A; Amar L
    Heart; 2013 Oct; 99(19):1438-44. PubMed ID: 23837998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence and Clinical Presentation of Pheochromocytoma and Sympathetic Paraganglioma: A Population-based Study.
    Ebbehoj A; Stochholm K; Jacobsen SF; Trolle C; Jepsen P; Robaczyk MG; Rasmussen ÅK; Feldt-Rasmussen U; Thomsen RW; Søndergaard E; Poulsen PL
    J Clin Endocrinol Metab; 2021 Apr; 106(5):e2251-e2261. PubMed ID: 33479747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of pheochromocytomas and abdominal and pelvic paragangliomas with head and neck paragangliomas.
    Al-Harthy M; Al-Harthy S; Al-Otieschan A; Velagapudi S; Alzahrani AS
    Endocr Pract; 2009 Apr; 15(3):194-202. PubMed ID: 19364686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The clinical implication of left ventricular hypertrophy in patients with pheochromocytoma and paraganglioma].
    Ding L; Fang L; Zhu W; Zeng Z; Li H
    Zhonghua Xin Xue Guan Bing Za Zhi; 2014 Dec; 42(12):1029-34. PubMed ID: 25623350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pheochromocytoma/Paraganglioma: Review of perioperative management of blood pressure and update on genetic mutations associated with pheochromocytoma.
    Fishbein L; Orlowski R; Cohen D
    J Clin Hypertens (Greenwich); 2013 Jun; 15(6):428-34. PubMed ID: 23730992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute cardiac complications and subclinical myocardial injuries associated with pheochromocytoma and paraganglioma.
    Zhou J; Xuan H; Miao Y; Hu J; Dai Y
    BMC Cardiovasc Disord; 2021 Apr; 21(1):203. PubMed ID: 33882857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of hypertension with or without diabetes on left ventricular remodeling in rural Chinese population: a cross-sectional study.
    Li T; Chen S; Guo X; Yang J; Sun Y
    BMC Cardiovasc Disord; 2017 Jul; 17(1):206. PubMed ID: 28750662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retinal arterial remodeling in patients with pheochromocytoma or paraganglioma and its reversibility following surgical treatment.
    Gosk-Przybyłek M; Doroszko A; Dobrowolski P; Warchoł-Celińska E; Harazny J; Bińczyk E; Szymanek K; Pęczkowska M; Kabat M; Toutounchi S; Gałązka Z; Górnicka B; Szaflik J; Januszewicz M; Klisiewicz A; Hoffman P; Lenders JWM; Eisenhofer G; Szaflik JP; Schmieder RE; Prejbisz A; Januszewicz A
    J Hypertens; 2020 Aug; 38(8):1551-1558. PubMed ID: 32205562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of body composition and genotype on haemodynamics during surgery for pheochromocytoma and paraganglioma.
    Pang Y; Li M; Jiang J; Chen X; Fu Y; Wang C; He Y; Zhao Y; Wang Y; Guan X; Zhang L; Xu X; Gan Y; Liu Y; Xie Y; Tang T; Wang J; Xie B; Liang Z; Chen D; Liu H; Chen C; Eisenhofer G; Liu L; Yi X; Chen BT
    J Cachexia Sarcopenia Muscle; 2022 Dec; 13(6):2843-2853. PubMed ID: 36068986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Role for Metyrosine in the Treatment of Patients With Pheochromocytoma and Paraganglioma.
    Gruber LM; Jasim S; Ducharme-Smith A; Weingarten T; Young WF; Bancos I
    J Clin Endocrinol Metab; 2021 May; 106(6):e2393-e2401. PubMed ID: 33693908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood Pressure Profile, Catecholamine Phenotype, and Target Organ Damage in Pheochromocytoma/Paraganglioma.
    Petrák O; Rosa J; Holaj R; Štrauch B; Krátká Z; Kvasnička J; Klímová J; Waldauf P; Hamplová B; Markvartová A; Novák K; Michalský D; Widimský J; Zelinka T
    J Clin Endocrinol Metab; 2019 Nov; 104(11):5170-5180. PubMed ID: 31009053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.